Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
BCLI

BrainStorm

$3.48

-0.01 (-0.29%)

08:43
01/22/19
01/22
08:43
01/22/19
08:43
Hot Stocks
BrainStorm granted additional patent for NurOwn in Israel »

BrainStorm Cell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
NVS

Novartis

$85.88

1.1 (1.30%)

, JNJ

Johnson & Johnson

$127.80

1.99 (1.58%)

04:55
01/06/19
01/06
04:55
01/06/19
04:55
Conference/Events
Sachs Associates to hold a forum »

2nd Annual Neuroscience…

NVS

Novartis

$85.88

1.1 (1.30%)

JNJ

Johnson & Johnson

$127.80

1.99 (1.58%)

LLY

Eli Lilly

$114.65

3.36 (3.02%)

BIIB

Biogen

$318.19

11.62 (3.79%)

AGN

Allergan

$142.64

6.59 (4.84%)

NTRP

Neurotrope

$3.85

0.04 (1.05%)

CCORF

Canaccord Financial

$0.00

(0.00%)

BCLI

BrainStorm

$3.37

-0.03 (-0.88%)

TNXP

Tonix Pharmaceuticals

$2.15

0.07 (3.37%)

CVSI

CV Sciences

$0.00

(0.00%)

CGC

Canopy Growth

$28.21

0.09 (0.32%)

ABBV

AbbVie

$89.04

2.89 (3.35%)

SF

Stifel Financial

$42.09

2.06 (5.15%)

RLMD

Relmada Therapeutics

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

  • 06

    Jan

  • 06

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 14

    Jan

  • 14

    Jan

  • 22

    Jan

  • 25

    Jan

  • 27

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 18

    Feb

  • 18

    May

  • 28

    May

NVS

Novartis

$85.88

1.1 (1.30%)

, JNJ

Johnson & Johnson

$127.80

1.99 (1.58%)

13:29
01/05/19
01/05
13:29
01/05/19
13:29
Conference/Events
Sachs Associates to hold a forum »

2nd Annual Neuroscience…

NVS

Novartis

$85.88

1.1 (1.30%)

JNJ

Johnson & Johnson

$127.80

1.99 (1.58%)

LLY

Eli Lilly

$114.65

3.36 (3.02%)

BIIB

Biogen

$318.19

11.62 (3.79%)

AGN

Allergan

$142.64

6.59 (4.84%)

NTRP

Neurotrope

$3.85

0.04 (1.05%)

CCORF

Canaccord Financial

$0.00

(0.00%)

BCLI

BrainStorm

$3.37

-0.03 (-0.88%)

TNXP

Tonix Pharmaceuticals

$2.15

0.07 (3.37%)

CVSI

CV Sciences

$0.00

(0.00%)

CGC

Canopy Growth

$28.21

0.09 (0.32%)

ABBV

AbbVie

$89.04

2.89 (3.35%)

SF

Stifel Financial

$42.09

2.06 (5.15%)

RLMD

Relmada Therapeutics

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 06

    Jan

  • 06

    Jan

  • 07

    Jan

  • 07

    Jan

  • 07

    Jan

  • 14

    Jan

  • 14

    Jan

  • 22

    Jan

  • 25

    Jan

  • 27

    Jan

  • 28

    Jan

  • 29

    Jan

  • 29

    Jan

  • 18

    Feb

  • 18

    May

  • 28

    May

BCLI

BrainStorm

$3.24

0.02 (0.62%)

07:51
12/27/18
12/27
07:51
12/27/18
07:51
Hot Stocks
BrainStorm will focus on ALS study enrollment, MS studies initiation in 2019 »

In its 2018 letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

BCLI

BrainStorm

$3.22

-0.21 (-6.12%)

05:17
12/26/18
12/26
05:17
12/26/18
05:17
Hot Stocks
BrainStorm expands manufacturing of NurOwn for Phase 2 progressive MS trial »

BrainStorm Cell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jan

Over a month ago
BCLI

BrainStorm

$3.17

0.02 (0.63%)

08:08
11/19/18
11/19
08:08
11/19/18
08:08
Hot Stocks
BrainStorm submits IND to FDA for NurOwn »

BrainStorm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCLI

BrainStorm

$3.35

0.13 (4.04%)

10:53
10/29/18
10/29
10:53
10/29/18
10:53
Recommendations
BrainStorm analyst commentary at H.C. Wainwright »

BrainStorm's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

BCLI

BrainStorm

$3.35

0.13 (4.04%)

10:47
10/29/18
10/29
10:47
10/29/18
10:47
Earnings
BrainStorm reports Q3 EPS (15c), two estimates (10c) »

Reports no revenue, two…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

Over a quarter ago
VCEL

Vericel

$14.37

-0.54 (-3.62%)

, FLXN

Flexion

$18.24

-0.56 (-2.98%)

04:55
10/05/18
10/05
04:55
10/05/18
04:55
Conference/Events
Alliance for Regenerative Medicine (ARM) to hold a conference »

Cell & Gene Meeting…

VCEL

Vericel

$14.37

-0.54 (-3.62%)

FLXN

Flexion

$18.24

-0.56 (-2.98%)

MDXG

MiMedx

$6.46

0.12 (1.89%)

ADAP

Adaptimmune

$14.18

0.07 (0.50%)

ABEO

Abeona Therapeutics

$11.43

-0.47 (-3.95%)

BCLI

BrainStorm

$3.75

-0.14 (-3.60%)

TIG

TiGenix

$0.00

(0.00%)

AVRO

Avrobio

$23.35

-0.1 (-0.43%)

JUNO

Acquired by CELG

$0.00

(0.00%)

BTX

BioTime

$2.22

-0.04 (-1.77%)

NITE

Nightstar Therapeutics

$17.99

-0.65 (-3.49%)

BLUE

Bluebird Bio

$140.70

-3.36 (-2.33%)

AST

Asterias

$1.15

-0.15 (-11.54%)

GSK

GlaxoSmithKline

$40.16

-0.345 (-0.85%)

WXXWY

Wuxi Biologics

$0.00

(0.00%)

CLBS

Caladrius

$5.51

0.01 (0.18%)

SGMO

Sangamo

$14.82

-0.51 (-3.33%)

BOLD

Audentes Therapeutics

$34.22

-0.76 (-2.17%)

ONVO

Organovo

$1.14

-0.02 (-1.72%)

SNY

Sanofi

$44.10

-0.51 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

  • 09

    Oct

  • 19

    Oct

  • 20

    Oct

  • 28

    Oct

  • 29

    Oct

  • 01

    Dec

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

BCLI

BrainStorm

$3.89

0.17 (4.57%)

09:28
10/04/18
10/04
09:28
10/04/18
09:28
Hot Stocks
BrainStorm announces results from NurOwn Phase 2 trial »

BrainStorm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.